Loading…
Based on limited metadata, RIJ Pharmaceutical LLC, a pharmaceutical drug manufacturer, received an FDA Warning Letter on March 28, 2019. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product oversight, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to assess the specific regulatory violations cited.